SALK NEWS

Salk Institute for Biological Studies - SALK NEWS

Salk News


Protein plays unexpected role in embryonic stem cells

LA JOLLA–What if you found out that pieces of your front door were occasionally flying off the door frame to carry out chores around the house? That’s the kind of surprise scientists at the Salk Institute experienced with their recent discovery that nucleoporins–proteins that act as cellular “doorways” to help manage what goes in and out of a cell’s nucleus–are actually much bigger players in expressing genes than previously thought.


Salk Institute scientist Nicola Allen named Pew Scholar

LA JOLLA–The Pew Charitable Trusts announced today that Salk Institute scientist Nicola Allen, an assistant professor in the Molecular Neurobiology Laboratory, is one of 22 researchers to be named a Pew Scholar in the Biomedical Sciences. Allen joins the ranks of more than 600 outstanding scientists who have been selected as Pew scholars in the 30 years since the program’s inception.


Salk Institute board of trustees elects neuroscientist Thomas M. Jessell and business leader Daniel Tierney

LA JOLLA, CA–The Salk Institute is pleased to announce the election of neuroscientist Thomas M. Jessell and business leader Daniel Tierney to its Board of Trustees. The Board voted on the appointments in April.


Low glycemic index diet reduces symptoms of autism in mice

LA JOLLA–Bread, cereal and other sugary processed foods cause rapid spikes and subsequent crashes in blood sugar. In contrast, diets made up of vegetables, fruits and whole grains are healthier, in part because they take longer to digest and keep us more even-keeled.


Salk scientists reveal epigenome maps of the human body’s major organs

LA JOLLA–For more than a decade, scientists have had a working map of the human genome, a complete picture of the DNA sequence that encodes human life. But new pages are still being added to that atlas: maps of chemical markers called methyl groups that stud strands of DNA and influence which genes are repressed and when.


Salk recruits human geneticist Graham McVicker

LA JOLLA–Expanding on its leadership in genetics, the Salk Institute is pleased to announce the appointment of Graham McVicker as an assistant professor in the Center for Integrative Biology and in the Laboratory of Genetics.


Brain cells capable of “early-career” switch

LA JOLLA–Scientists at the Salk Institute have discovered that the role of neurons–which are responsible for specific tasks in the brain–is much more flexible than previously believed.


Joanne Chory elected to the American Philosophical Society

Salk scientist Joanne Chory, a professor in the Plant Molecular and Cellular Biology Laboratory, has received the prestigious honor of being elected to the American Philosophical Society (APS). The APS is an eminent scholarly organization of international reputation, which promotes useful knowledge in the sciences and humanities. This country’s first learned society, the APS has played an important role in American cultural and intellectual life for over 250 years.


New stem cell may overcome hurdles for regenerative medicine

LA JOLLA–Scientists at the Salk Institute have discovered a novel type of pluripotent stem cell–cells capable of developing into any type of tissue–whose identity is tied to their location in a developing embryo. This contrasts with stem cells traditionally used in scientific study, which are characterized by their time-related stage of development.


Vital step in stem cell growth revealed

LA JOLLA–Stem cells, which have the potential to turn into any kind of cell, offer the tantalizing possibility of generating new tissues for organ replacements, stroke victims and patients of many other diseases. Now, scientists at the Salk Institute have uncovered details about stem cell growth that could help improve regenerative therapies.


Scientists discover key driver of human aging

LA JOLLA–A study tying the aging process to the deterioration of tightly packaged bundles of cellular DNA could lead to methods of preventing and treating age-related diseases such as cancer, diabetes and Alzheimer’s disease, as detailed April 30, 2015, in Science.


Salk Institute Professor Vicki Lundblad elected to National Academy of Sciences

LA JOLLA—The National Academy of Sciences (NAS) recently announced that Salk Institute Professor Vicki Lundblad is one of 84 new members to be elected to the NAS. The election is considered one of the highest honors accorded a U.S. scientist. Lundblad’s recognition brings the number of Salk faculty elected to the NAS to 14.


Gene-editing technique offers hope for hereditary diseases

LA JOLLA–For thousands of women around the globe carrying a mitochondrial disease, having a healthy child can be a gamble. This set of diseases affect mitochondria, tiny powerhouses that generate energy in the body’s cells and are passed exclusively from mother to child.


Salk scientists Joseph Ecker and Dennis O’Leary elected to American Academy of Arts & Sciences

LA JOLLA–Salk Institute Professors Joseph Ecker and Dennis O’Leary have received the prestigious honor of being elected to the American Academy of Arts and Sciences (AAAS) class of 2015. One of the nation’s most prominent honorary societies, AAAS are among the 197 accomplished leaders from academia, business, public affairs, the humanities and the arts accepted to this year’s class. Its members include winners of the Nobel Prize and Pulitzer Prize; MacArthur and Guggenheim Fellowships; and Grammy, Emmy, Oscar and Tony Awards.


How the brain balances risk-taking and learning

LA JOLLA–If you had 10 chances to roll a die, would you rather be guaranteed to receive $5 for every roll ($50 total) or take the risk of winning $100 if you only roll a six?


Food for thought: Master protein enhances learning and memory

LA JOLLA–Just as some people seem built to run marathons and have an easier time going for miles without tiring, others are born with a knack for memorizing things, from times tables to trivia facts. These two skills–running and memorizing–are not so different as it turns out.


The Salk Institute opens its doors for 3rd annual Explore Salk, a free community open house

The Salk Institute will open its doors to the community Saturday, April 11, for the third annual Explore Salk, a once-a-year event featuring staff-guided lab tours, self-guided architectural tours, science booths and talks by eminent Salk researchers. Family friendly activities include a Kids’ Discovery Zone, a mobile science lab with hands-on experiments and a virtual lab tour with a Q&A session for preteens interested in pursuing a career in science.


Immune system-in-a-dish offers hope for “bubble boy” disease

LA JOLLA–For infants with severe combined immunodeficiency (SCID), something as simple as a common cold or ear infection can be fatal. Born with an incomplete immune system, kids who have SCID–also known as “bubble boy” or “bubble baby” disease–can’t fight off even the mildest of germs. They often have to live in sterile, isolated environments to avoid infections and, even then, most patients don’t live past a year or two. This happens because stem cells in SCID patients’ bone marrow have a genetic mutation that prevents them from developing critical immune cells, called T and Natural Killer (NK) cells.


Cellular scissors chop up HIV virus

LA JOLLA–Imagine a single drug that could prevent human immunodeficiency virus (HIV) infection, treat patients who have already contracted HIV, and even remove all the dormant copies of the virus from those with the more advanced disease. It sounds like science fiction, but Salk scientists have gotten one step closer to creating such a drug by customizing a powerful defense system used by many bacteria and training this scissor-like machinery to recognize the HIV virus.


Tony Hunter wins BBVA Foundation Frontiers of Knowledge Award in Biomedicine

LA JOLLA–Tony Hunter, professor and director of the Salk Institute Cancer Center, in La Jolla, California, has received the BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category for “carving out the path that led to the development of a new class of successful cancer drugs.”